UnitedHealth Group (UNH)
285.61
-1.96 (-0.68%)
NYSE · Last Trade: Mar 18th, 2:46 PM EDT
Detailed Quote
| Previous Close | 287.57 |
|---|---|
| Open | 285.20 |
| Bid | 285.61 |
| Ask | 285.72 |
| Day's Range | 284.64 - 288.40 |
| 52 Week Range | 234.60 - 606.36 |
| Volume | 2,073,294 |
| Market Cap | 258.76B |
| PE Ratio (TTM) | 21.64 |
| EPS (TTM) | 13.2 |
| Dividend & Yield | 8.840 (3.10%) |
| 1 Month Average Volume | 7,506,671 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
The financial markets were jolted this week as the Federal Reserve’s preferred inflation metric, the Core Personal Consumption Expenditures (PCE) price index, unexpectedly climbed to 3.0% on an annualized basis. This surge in "early 2026" data marks a stark departure from the Consumer Price Index (CPI), which has
Via MarketMinute · March 18, 2026
In the face of the most aggressive antitrust environment in decades and the sweeping legislative changes of the 2025 "One Big Beautiful Bill Act" (OBBBA), the healthcare sector has not retreated from its consolidation ambitions. Instead, strategic buyers have evolved, trading the broad "mega-merger" attempts of the past for targeted,
Via MarketMinute · March 18, 2026
The landscape of American corporate deal-making has undergone a seismic shift as of March 2026. Following years of aggressive, litigation-heavy enforcement that saw many major mergers stalled or abandoned, a new regulatory era has emerged under the current administration. By moving away from the "block-at-all-costs" philosophy of the early 2020s
Via MarketMinute · March 18, 2026
The worst seems like it's behind this healthcare giant.
Via The Motley Fool · March 17, 2026
UnitedHealth Group (NYSE: UNH) will release its first quarter 2026 financial results on Tuesday, April 21, 2026, before the market opens, and will host a teleconference at 8:00 a.m. ET with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com). The replay will be available through May 5, 2026, on the website.
By UnitedHealth Group · Via Business Wire · March 17, 2026
Scott+Scott Attorneys at Law LLP has launched an urgent investigation into whether certain officers and directors of UnitedHealth Group Incorporated (NYSE: UNH) failed to manage UnitedHealth Group in an acceptable manner, breaching their fiduciary duties to UnitedHealth Group, and whether UnitedHealth Group and its shareholders have suffered damages as a result. Attorney Joseph A. Pettigrew is heading the investigation—what shareholders need to know:
By Scott+Scott Attorneys at Law LLP · Via Business Wire · March 17, 2026
As the first quarter of 2026 draws to a close, the S&P 500 is witnessing one of the most dramatic sector performance splits in recent financial history. According to consensus estimates as of March 17, 2026, the Finance sector is projected to report a staggering 19% year-over-year earnings growth,
Via MarketMinute · March 17, 2026
As of March 16, 2026, the Dow Jones Industrial Average is locked in a high-stakes tug-of-war between mounting geopolitical pressures and a desperate technical recovery. After a blistering 2025 that saw the index touch historic heights, the first quarter of 2026 has been defined by a "triple macro shock"—an
Via MarketMinute · March 16, 2026
Amidst a backdrop of mounting geopolitical tensions and sharp swings in the broader indices, pharmaceutical giant Merck & Co. (NYSE: MRK) officially trades ex-dividend today, March 16, 2026. Investors who held the stock prior to today’s session are now locked in to receive a quarterly payout of $0.85 per
Via MarketMinute · March 16, 2026
The Federal Reserve’s preferred inflation gauge, the Core Personal Consumption Expenditures (PCE) price index, delivered a sobering message to Wall Street this past Friday. Data released on March 13, 2026, revealed that core prices rose by 0.4% in January, a figure that matched the previous month’s high
Via MarketMinute · March 16, 2026
UnitedHealthcare today announced the national expansion of its doula offering, now available to people enrolled in eligible health plans through their employer. Doula Support is designed to help improve maternal and infant health outcomes by giving more people access to non-clinical emotional, physical and educational support throughout their pregnancy, birth and the postpartum period.
By UnitedHealthcare · Via Business Wire · March 16, 2026
The United States labor market sent a chilling signal to investors and policymakers alike this week, as the Department of Labor reported a staggering loss of 92,000 nonfarm payroll jobs for February 2026. The report, released on March 6, completely upended economist expectations of a modest 50,000-job gain,
Via MarketMinute · March 13, 2026
In a much-anticipated data release that arrived later than scheduled, the U.S. Commerce Department reported today that consumer spending rose by 0.4% in January 2026. While the headline figure suggests a resilient American consumer, the underlying data reveals a more complex narrative: the cost of living continues to
Via MarketMinute · March 13, 2026
Wall Street is enduring a punishing midday session this Friday, March 13, 2026, as a "perfect storm" of geopolitical anxiety and shifting monetary expectations sends the major averages tumbling. The S&P 500 (NYSEARCA:SPY), the Dow Jones Industrial Average (INDEXDJX:.DJI), and the tech-heavy Nasdaq Composite (INDEXNASDAQ:.IXIC) are
Via MarketMinute · March 13, 2026
Despite the superstitions surrounding Friday the 13th, the U.S. stock market showed signs of a spirited recovery in early trading on March 13, 2026. Dow Jones Industrial Average and S&P 500 futures signaled a robust rebound, clawing back a significant portion of the losses sustained during Thursday’s
Via MarketMinute · March 13, 2026
The U.S. economy was dealt a staggering blow this month as the Department of Labor’s February Jobs Report revealed a sudden and unexpected contraction in the workforce. In a report released on March 6, 2026, nonfarm payrolls plummeted by 92,000, a figure that stood in stark contrast
Via MarketMinute · March 13, 2026
The long-standing resilience of the equity markets faced its most significant challenge in over a year today as the S&P 500 (NYSEARCA:SPY) decisively pierced key technical support levels. In a session marked by heavy institutional selling, the index fell through both its 100-day and 20-week moving averages, a
Via MarketMinute · March 12, 2026
The U.S. labor market sent shockwaves through global financial centers following the release of the February 2026 employment report, which revealed a staggering net loss of 92,000 jobs. This figure stood in stark contrast to economist expectations of a 70,000-job gain, marking the sharpest divergence from consensus
Via MarketMinute · March 12, 2026
Via Benzinga · March 11, 2026
The healthcare investment landscape was irrevocably altered this quarter as UnitedHealth Group (NYSE:UNH) witnessed a historic 20% collapse in its market valuation. The blue-chip titan, long considered the bedrock of the Dow Jones Industrial Average, shocked investors by forecasting its first annual revenue contraction in over 36 years. This
Via MarketMinute · March 11, 2026
As of March 11, 2026, the Dow Jones Industrial Average is grappling with a heavyweight problem. UnitedHealth Group (NYSE: UNH), long the gold standard of the managed care sector and a primary engine of the index’s growth over the last decade, has transformed into its most significant anchor. With
Via MarketMinute · March 11, 2026
On a day marked by deepening global uncertainty and a sharp spike in energy costs, the healthcare sector emerged as the primary beneficiary of a massive "risk-off" migration by institutional investors. As of the market close on March 10, 2026, the Healthcare Select Sector SPDR Fund (NYSEARCA:XLV) gained 1%
Via MarketMinute · March 10, 2026
The dominant narrative of the 2020s—a market driven by a handful of trillion-dollar technology titans—is facing its most significant challenge yet. As of March 10, 2026, the tide has officially turned, with investors aggressively rotating out of concentrated, market-cap-weighted indices in favor of equal-weight strategies. This shift is
Via MarketMinute · March 10, 2026
Centene has underperformed the Nasdaq recently, and analysts remain cautious about the stock’s prospects.
Via Barchart.com · March 10, 2026
The healthcare sector has entered a period of sharp divergence in early 2026, creating a "bifurcated market" where clinical innovation is rewarding a select few while punishing former industry darlings. As of March 10, 2026, the industry is processing a tale of two trajectories: Vertex Pharmaceuticals (NASDAQ: VRTX) has cemented
Via MarketMinute · March 10, 2026